Novartis gets FDA Priority Review for first-line treatment of advanced breast cancer
Novartis gets FDA Priority Review for first-line treatment of HR+/HER2-advanced breast cancer
Pharmaceuticals, Biotechnology and Life Sciences
Novartis gets FDA Priority Review for first-line treatment of HR+/HER2-advanced breast cancer
India’s Strides Shasun Limited has received approval from the USFDA for Abacavir Tablets
Avacta Group will present detailed data from the first pre-clinical in-vivo studies of its therapeutic Affimer platform
Advanced Oncotherapy has announced that Lord David Evans has stepped down
New way to to perform transcatheter aortic valve replacemen successful in high-risk patients
French Genfit has raised €78.5 million and invests in its R&D
Mylan NV’s price hikes on EpiPens have added millions to U.S. Department of Defense spending…
BD has gotten FDA market authorization for a first-of-its-kind molecular test…
HeartWare is recalling the HVAD controller due to a loose power connector which may cause …
Premaitha Health has gotten UK’s Department of Health approval to make non-invasive prenatal tests (“NIPT”)